This Week in Cardiology

 
 
  • Jul 8 2022 This Week in Cardiology   Questions about Vascepa (IPE) benefits in REDUCE-IT, US heart health, pharmacist prescribing, and who should get statins are the topics discussed this week
  • Jun 24 2022 This Week in Cardiology   A non-significant but wonderful trial in AF, smoking and HF, vitamins, and pre-op risk screening are the topics discussed by John Mandrola, MD, in this week’s podcast.
  • Jun 17 2022 This Week in Cardiology   Statin Intolerance, external validity of trials, contrast shortage, and expansion of cardiology into diabetes and nephrology are the topics John Mandrola, MD, discusses in this week’s podcast.
  • Jun 10 2022 This Week in Cardiology   More ISCHEMIA controversy, health Insurance and CV outcomes, testosterone, and flawed observational studies are the topics discussed by John Mandrola, MD in this week’s podcast.
  • Jun 3 2022 This Week in Cardiology   Devices for HF, Twitter for disseminating science, HDL levels, and dubious post-hoc studies are the topics John Mandrola, MD, discusses in this week’s podcast.
  • May 20 2022 This Week in Cardiology   Ischemia vs anatomic testing for CAD, UK-TAVI trial, TAVI for AR? and post-PCI anti-thrombotics are the topics John Mandrola, MD, discusses in this week’s podcast.
  • May 13 2022 This Week in Cardiology   Obstructive hypertrophic cardiomyopathy and mavacamten, SGLT2 inhibitors, the triple whammy, espresso, and clinician burnout are the topics John Mandrola, MD, covers in today’s podcast.
  • May 6 2022 This Week in Cardiology   HRS meeting presentations: conduction system pacing, AF in the ED, a possible new treatment for vagal bradycardia, and women in EP are the topics John Mandrola, MD, discusses in this week’s podcast.
  • Apr 29 2022 This Week in Cardiology   Aspirin for primary prevention, time-restricted feeding, renal denervation, and a potential new obesity drug are the topics John Mandrola, MD, covers in this week’s podcast.
  • Apr 22 2022 This Week in Cardiology   Critiques of last week’s comments on VT ablation and a review of EHRA presentations, including new ways to ablate atrial myocardium and pace the ventricle, are discussed by John Mandrola, MD, in this week’s podcast.
  • Apr 15 2022 This Week in Cardiology   ACC Recap, Part 2: VT ablation, HF care, three-vessel disease, and patiromer are the topics John Mandrola, MD, covers in this week's podcast.
  • Apr 8 2022 This Week in Cardiology   ACC Recap: John Mandrola, MD, provides part 1 of an ACC recap in this week’s podcast.
  • Apr 1 2022 This Week in Cardiology   Coronary CTA, semaglutide, coronary artery calcium, exercise, and an ACC and EHRA preview are the topics discussed by John Mandrola, MD, in this week’s podcast.
  • Mar 25 2022 This Week in Cardiology   AF ablation vs rate control in HF, TAVI vs SAVR, atherosclerosis, and surrogate endpoints in observational studies are the topics John Mandrola, MD, discusses in this week’s podcast.
  • Mar 11 2022 This Week in Cardiology   AF screening, CTA, stroke prevention and broken observational studies, and medical writing are the topics John Mandrola, MD discusses in this week’s podcast.
  • Mar 4 2022 This Week in Cardiology   An update to CardioMEMs post, ARBs and cancer, troponins, empagliflozin, and low-value care are the topics discussed by John Mandrola, MD, in this week’s podcast.
  • Feb 25 2022 This Week in Cardiology   FDA approval of CardioMEMS, statins, VT storm, and fish oil and AF are the topics covered by John Mandrola, MD, in this week’s podcast.
  • Feb 18 2022 This Week in Cardiology   Spinal cord stimulation to prevent post-cardiac surgery AF, statin intolerance, heart failure with preserved ejection fraction, and Vitamin D are discussed by John Mandrola, MD, in this week's podcast.
  • Feb 11 2022 This Week in Cardiology   LDL equations, stroke interventions, post-PCI antiplatelets, the transitive function and network meta-analysis, and lipoprotein(a) are the topics John Mandrola, MD, discusses in this week’s podcast.
  • Feb 4 2022 This Week in Cardiology   Interatrial shunt therapy, the power of the RCT, chronic stress, anxiety and cardiometabolic risk, and TAVR, are the topics covered by John Mandrola, MD, in this week’s podcast.